Cell & Gene Therapy Quality·6 min read
Chain of Custody Gaps That Trigger 483s
Autologous CAR-T manufacturing leaves almost no room for a custody break. Here are the patterns that most often turn into an FDA observation — and what a defensible chain of custody program looks like instead.
Read article